Advertisement
Screener

BIO-TECHNE Corp (TECH) Material Contracts

BIO-TECHNE Corp Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-24: Form 10-K; Exhibit 10.21; Description Form of Retention Agreement by and between the Company and Executive Officers of the Company--attached as Exhibit 10.21 hereto.
  • 2026-05-06: Form 10-Q; Exhibit 10.2; Description Executive Transition Agreement, dated March 1, 2026, between the Company and Dr. Matt McManus.
  • 2026-02-11: Form 8-K; Exhibit 10.1; Description Executive Employment Agreement, dated February 10, 2026, between the Company and Steve Crouse.
  • 2024-01-08: Form 8-K; Exhibit 10.1; Description Executive Employment Agreement, dated January 4, 2024, between the Company and Matthew McManus.
FiledFormExhibitDescription
2026-08-2410-K10.21Form of Retention Agreement by and between the Company and Executive Officers of the Company--attached as Exhibit 10.21 hereto
2026-05-0610-Q10.2Executive Transition Agreement, dated March 1, 2026, between the Company and Dr. Matt McManus
2026-02-118-K10.1Executive Employment Agreement, dated February 10, 2026, between the Company and Steve Crouse

Similar stocks

Stock NameCountryMarket CapPE Ratio
Twist Bioscience Corp (TWST)United States$11.540B-47.21
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78